Sartorius buys Cellca for process dev knowhow
Sartorius Stedim Biotech SA (SSB) has acquired cell line and process development contractor Cellca GmbH.
Archives for July 6, 2015
ReNeuron to automate stem cell stroke therapy production for Phase III trial
ReNeuron will automate processing of its stem cell-based stroke therapy ahead of planned Phase III trials using a system acquired from Sartorius Stedim Biotech (SSB) subsidiary, TAP Biosystems.